SYNBIOVEN
SynBioVen is focused on supporting the next generation of synthetic biology scientists, founders and start-ups.
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Alia Therapeutics
Alia Therapeutics is developing next-generation gene-editing medicines to cure rare genetic diseases.
Atamyo Therapeutics
Atamyo Therapeutics is focused on the development of a new generation of safe and effective gene therapies for neuromuscular diseases.
Borea Therapeutics
Borea Therapeutics is advancing a new generation of gene therapies that would enable the targeting of specific tissues and cells.
Delta 4
Delta 4 is a biotech startup driving the forefront of digital drug discovery and development.
OpenCell
OpenCell builds biotech labs in shipping containers with the aim of making biotechnology accessible and affordable.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Versameb
Versameb is focusing on the discovery and development of innovative, next-generation RNA-based drugs.
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2023-07-26 | CHAIN Biotechnology | SynBioVen investment in Seed Round - CHAIN Biotechnology | 1.8 M GBP |
| 2023-05-16 | Resurrect Bio | SynBioVen investment in Seed Round - Resurrect Bio | 1.61 M GBP |
| 2023-01-16 | Multus | SynBioVen investment in Series A - Multus | 7.9 M GBP |
| 2022-11-14 | Eden Bio | SynBioVen investment in Seed Round - Eden Bio | 1000 K GBP |
| 2022-04-28 | Scindo | SynBioVen investment in Seed Round - Scindo | N/A |
More informations about "SynBioVen"
About | SynBioVen
SynBioVen is a supporting founders in Synthetic Biology with PoC, pre-seed and seed funding and technical expertise. top of page. Home. Mission. Portfolio. Contact. About. More. Leadership Team. Sir David Harding. Founder and …See details»
SynBioVen - Crunchbase Investor Profile & Investments
Find More Contacts for SynBioVen. Protected Content. Director. Director 1 email found . View contacts for SynBioVen to access new leads and connect with decision-makers. View All Contacts . Details. Edit Details Section. …See details»
SynBioVen - LinkedIn
SynBioVen | 240 followers on LinkedIn. We partner with synthetic biology founders from day 1 | SBV is a new investment vehicle focused on supporting the next generation of SynBio scientists ...See details»
SynBioVen - Investments, Portfolio & Company Exits - Crunchbase
SynBioVen is focused on supporting the next generation of synthetic biology scientists, founders and start-ups. Search Crunchbase. Start Free Trial . Chrome Extension. ... Which industries …See details»
SynBioVen investment portfolio - PitchBook
SynBioVen General Information Company Description. Founded in 2022, SynBioVen is a venture capital investment firm based in London, United Kingdom. The firm seeks to invest in the …See details»
National hub to support synthetic biology extended …
Jul 19, 2022 The funding from SynBioVen will continue to support our national programme to de-risk investment in the UK synthetic biology sector.” Professor Paul Freemont , Co-Director of SynbiCITE, added: “Over the last few years, …See details»
SynBioVen - Team & Partners - Tracxn
Oct 22, 2024 SynBioVen team. Venture capital fund focused on early-stage synthetic biological companiesSee details»
SynBioVen - Investor Profile, Portfolio & Team - Tracxn
Jul 17, 2024 SynBioVen - Venture capital fund focused on early-stage synthetic biological companies. Portfolio of 7 companies. 19 investors have invested with SynBioVen. Team has 1 …See details»
SynBioVen - Contacts, Employees, Board Members, Advisors
SynBioVen is focused on supporting the next generation of synthetic biology scientists, founders and start-ups.See details»
National hub to support synthetic biology extended with £5.5m …
Jul 19, 2022 In addition to the funding for the centre, SynBioVen has £15 million available to support the development of these companies through investment which is vital for effective …See details»
Generare snaps €5M to discover next-gen medicines hiding in …
Oct 8, 2024 Generare, a French biotech startup, which discovers next-generation medicines and high-value molecules hiding in soil bacteria, has raised €5 million in seed funding. The investment came from Teampact.ventures, Galion.Exe and EU-backed VIVES Partners. Synbioven, Saras Capital and Better Angle also participated among a host of renowned business angels.See details»
CHAIN Biotech secures seed funding to advance CADD platform …
CHAIN Biotech secures seed funding to advance CADD platform for Immune-Oncology. CHAIN have closed a financing round led by new investors, BGF and SynBioVen, alongside existing …See details»
CHAIN Biotech closes seed round to accelerate development of its …
Jul 26, 2023 About SynBioVen. SynBioVen was formed in early 2022 to invest in and actively support early-stage, UK companies leveraging synthetic biology to build new platform and …See details»
UK biotech startup Resurrect Bio completes seed investment …
May 17, 2023 The investment was led by SynBioVen, and also included UKI2S, AgFunder and SHAKE Climate Change Accelerator. Resurrect Bio is a spin out company of The Sainsbury Laboratory in Norwich. It is building a platform that leverages gene editing techniques to fix the innate immune system of crops and make crops more resistant to disease, which is ...See details»
SynBioBeta
For example, he was Co-founder and Chairman of Visbion Ltd (until December 2022) – a medical imaging and biomedical information systems company, with over 1000 installations in 10 …See details»
SynBioVen - Crunchbase
SynBioVen is focused on supporting the next generation of synthetic biology scientists, founders and start-ups.See details»
SYNBIOVEN LIMITED Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for SYNBIOVEN LIMITED of LONDON. Get the latest business insights from Dun & Bradstreet. SYNBIOVEN …See details»
Synthetic Biology Market Size, Industry Share | Forecast, 2032
For instance, in July 2022, SynbiCITE, the U.K. National Centre for the Industrial Translation of Synthetic Biology, received a USD 5.38 million funding commitment from SynBioVen. …See details»
SynBioVen - VC Firm Profile - Gaebler.com Venture Capital …
Founded in 2022, SynBioVen is a venture capital investment firm based in the United Kingdom. The firm seeks to invest in the healthcare and biotechnology sectors. ProfileSee details»